Under construction – not a live service
Sign in
Taking people in EgyptPhase 3

Tests statins and ARBs for rheumatoid arthritis activity in Egyptian patients

Compares two drug types, statins and ARBs, in adults with rheumatoid arthritis.

Plain-language title generated from the registry record
Registry title: Statins and ARBs on Rheumatoid Activity

Key facts

Where
Tanta, EgyptSee the site
Phase
Phase 3

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT03770702, who can take part

Where in Egypt

  • Sherief Abd-ElsalamTanta, EgyptTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Sherief Abd-Elsalam
Trial code
NCT03770702
Record updated
10 December 2018
Original description
Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patientsRead full original descriptionShow less

Investigational and Comparative Study Between the Anti-inflammatory Effectof Both Angiotensin Reeptor Blockers and Statins on Rheumatoid Arthritis Disease Activity on Egyptian Patients

Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients

Inclusion: Rheumatoid arthritis.

Exclusion: Hepatic or renal impairment; Pregnant or lactating.

ClinicalTrials.gov NCT03770702